Dimensional Fund Advisors Portfolio holdings
Dimensional Fund Advisors (DFA), founded in 1981 by David Booth and Rex Sinquefield and headquartered in Austin, Texas, is an investment management firm renowned for its evidence-based, low-cost approach to investing, grounded in academic research from Nobel laureates like Eugene Fama and Kenneth French. Managing hundreds of billions in assets, DFA focuses on systematic, passive strategies that tilt toward factors like small-cap, value, and profitability stocks, primarily through mutual funds and institutional portfolios rather than retail brokerage services. The firm’s philosophy eschews market timing and stock picking, instead emphasizing diversification and efficient market exposure, often requiring investors to access its funds through approved financial advisors. With a global presence and a reputation for disciplined, data-driven investing, DFA has carved a unique niche in the industry, blending academic rigor with practical application.
Top Buys
| 1 |
Merck
MRK
|
$446M |
| 2 |
NVIDIA
NVDA
|
$375M |
| 3 |
Apple
AAPL
|
$319M |
| 4 |
EXE
Expand Energy Corporation Common Stock
EXE
|
$317M |
| 5 |
Meta Platforms (Facebook)
META
|
$310M |
Top Sells
| 1 |
SWN
Southwestern Energy Company
SWN
|
$381M |
| 2 |
Exxon Mobil
XOM
|
$324M |
| 3 |
MRO
Marathon Oil Corporation
MRO
|
$223M |
| 4 |
SoFi Technologies
SOFI
|
$160M |
| 5 |
VSTO
Vista Outdoor Inc.
VSTO
|
$136M |
Sector Composition
| 1 | Technology | 20.48% |
| 2 | Financials | 18.31% |
| 3 | Industrials | 12.27% |
| 4 | Consumer Discretionary | 10.89% |
| 5 | Healthcare | 9.53% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
3151
Nortech Systems
NSYS
$26.1M
| $218K | ﹤0.01% |
20,020
-485
| -2% | -$5.29K |
|
3152
American Well
AMWL
$112M
| $217K | ﹤0.01% |
29,951
+779
| +3% | +$5.65K |
|
3153
Kentucky First Federal Bancorp
KFFB
$25.3M
| $217K | ﹤0.01% |
72,375
-1,549
| -2% | -$4.65K |
|
3154
Kezar Life Sciences
KZR
$29.4M
| $217K | ﹤0.01% |
+32,310
| New | +$217K |
|
3155
PepGen
PEPG
$48.9M
| $216K | ﹤0.01% |
57,102
+11,870
| +26% | +$45K |
|
3156
Turkcell
TKC
$4.73B
| $216K | ﹤0.01% |
33,150
+3,767
| +13% | +$24.5K |
|
3157
Jerash Holdings
JRSH
$43.7M
| $215K | ﹤0.01% |
62,920
+3,760
| +6% | +$12.8K |
|
3158
Big 5 Sporting Goods
BGFV
$32.8M
| $214K | ﹤0.01% |
119,380
-109,163
| -48% | -$195K |
|
3159
Precision BioSciences
DTIL
$58.6M
| $211K | ﹤0.01% |
+55,475
| New | +$211K |
|
|
ENZ
3160
DELISTED
Enzo Biochem, Inc.
ENZ
| $211K | ﹤0.01% |
295,677
-8,815
| -3% | -$6.29K |
|
3161
Trinseo
TSE
$86.3M
| $210K | ﹤0.01% |
+41,224
| New | +$210K |
|
3162
Pioneer Power Solutions
PPSI
$42.3M
| $205K | ﹤0.01% |
49,638
-9,451
| -16% | -$39K |
|
3163
Amylyx Pharmaceuticals
AMLX
$931M
| $205K | ﹤0.01% |
+54,114
| New | +$205K |
|
3164
Santander
BSBR
$40.1B
| $204K | ﹤0.01% |
52,212
+25,985
| +99% | +$102K |
|
3165
Natural Health Trends
NHTC
$53.2M
| $202K | ﹤0.01% |
43,760
+2,274
| +5% | +$10.5K |
|
3166
Mineralys Therapeutics
MLYS
$2.79B
| $202K | ﹤0.01% |
+16,412
| New | +$202K |
|
3167
Bilibili
BILI
$9.31B
| $200K | ﹤0.01% |
+11,045
| New | +$200K |
|
3168
Lightpath Technologies
LPTH
$228M
| $193K | ﹤0.01% |
54,543
| – | – |
|
3169
PMV Pharmaceuticals
PMVP
$74.2M
| $190K | ﹤0.01% |
126,004
| – | – |
|
3170
Air Industries Group
AIRI
$15.3M
| $190K | ﹤0.01% |
+46,721
| New | +$190K |
|
3171
Corbus Pharmaceuticals
CRBP
$121M
| $190K | ﹤0.01% |
16,075
| – | – |
|
3172
Flexible Solutions
FSI
$121M
| $190K | ﹤0.01% |
52,499
+11,017
| +27% | +$39.8K |
|
|
BMTX
3173
DELISTED
BM Technologies, Inc.
BMTX
| $188K | ﹤0.01% |
38,475
+8,175
| +27% | +$40K |
|
3174
Expensify
EXFY
$181M
| $187K | ﹤0.01% |
+55,629
| New | +$187K |
|
|
RDIB
3175
Reading International Class B
RDIB
$280M
| $185K | ﹤0.01% |
23,454
-329
| -1% | -$2.6K |
|